Archives: Speakers

Janet Lee leads Cell Line Development group at Samsung Biologics. Her group has developed over 60 CLD projects successfully including complex biologics. She has over 25 years of biologics drug development experience specializing in Cell Line Development & Upstream Manufacturing Process development from global biotech companies in US. She joined Samsung Biologics team in 2015 as a MSAT Scientist and led number of Tech transfer programs for key commercial biologics.

Daniel Buckley is a Lead Scientist in CDO Downstream at Samsung Biologics. He has an extensive background in the biotech industry, with more than 17 years of experience in new product introductions, purification scale-up, biotech facility design, biotech facility C&Q, process validation, commercial manufacturing, audit readiness, and regulatory inspections. Prior to joining Samsung Biologics, Daniel served as manager for two downstream purification facilities at Eli Lilly.